Brightsurf Science News & Current Events

August 02, 2009
Finding the right connection after spinal cord injury
In a major step in spinal cord injury research, scientists at the University of California, San Diego School of Medicine have demonstrated that regenerating axons can be guided to their correct targets and reform connections after spinal cord injury.

Diagnostic tools and innovative therapies improve patient prognosis
The world's top lung cancer specialists, medical professionals and researchers are convening this week in San Francisco, Calif., for the 13th World Conference on Lung Cancer, organized by the International Association for the Study of Lung Cancer.

Stem cell 'daughters' lead to breast cancer
Walter and Eliza Hall Institute scientists have found that a population of breast cells called luminal progenitor cells are likely to be responsible for breast cancers that develop in women carrying mutations in the gene BRCA1.

HIV integrase inhibitor effective for patients beginning antiretroviral treatment
A member of a new class of antiretroviral drugs is safe and effective for patients beginning treatment against HIV, according to researchers who have completed a two-year multisite phase III clinical trial comparing it with standard antiretroviral drugs.

Variation in prostate stem cell antigen gene raises bladder cancer risk
Researchers have pinpointed a specific gene variation that causes increased risk of urinary bladder cancer, according to a scientific team led by the University of Texas M.

Scientists learn why even treated genital herpes sores boost the risk of HIV infection
New research helps explain why infection with herpes simplex virus-2 (HSV-2), which causes genital herpes, increases the risk for HIV infection even after successful treatment heals the genital skin sores and breaks that often result from HSV-2.

Yale scientists develop 'gas gauge' to prevent pregnancy loss
To combat the many fetal deaths that occur annually because the placenta is too small, researchers at Yale School of Medicine have developed a method to measure the volume of the placenta, which provides nourishment to the fetus.

Raltegravir combination treatment for HIV is a safe and effective alternative to efavirenz
Use of the HIV antiretroviral treatment raltegravir, in combination with optimum background therapy, is a safe and effective alternative to conventional combination treatment using efavirenz in patients yet to start antiretroviral treatment. is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to